UHS (UHS) Q3 2026 Earnings Call Transcript

UHS reported Q3 2026 adjusted EPS of $5.22, down 8% YoY, with adjusted EBITDA less NCI at $625M. Key factors included Medicaid benefits, litigation reserves, and Talkspace acquisition costs. The company highlighted investments in acute care capacity, Talkspace integration, and Laurel Ridge recertification. Acute care admissions rose 4.9%, but surgeries fell 0.7%.

Original reporting
Published Oct 28, 2026, 5:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 5:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UHS (UHS) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$UHSBearishHigh
01

Why it matters

The earnings miss and guidance outlook suggest near‑term pressure, but the acquisition synergies could be a catalyst later in 2027.

02

Market read

UHS earnings are a primary driver for the healthcare services sector today.

03

What to watch

One‑time Medicaid benefits and litigation reserves boosted results; underlying operating performance remains weak.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Universal Health Services (UHS) provided its Q3 2026 earnings call, highlighting operational metrics, Medicaid benefits, litigation reserves, and the recent Talkspace acquisition.

Company-level read

Ticker impact

$UHSBearishHigh confidence
Context

Q3 2026 earnings call disclosed adjusted EPS of $5.22, an 8% YoY decline and EBITDA miss.

Expected impact

potential downside as investors price in lower earnings and EBITDA.

Evidence & confidence

Adjusted EPS fell 8% YoY and adjusted EBITDA missed internal expectations despite one‑time benefits.

Market effects

May weigh on the broader hospital services sector as peers face similar Medicaid and litigation pressures.

Limited to U.S. healthcare investors; no immediate global effect.

Low; primarily a U.S. equities story.

Counterpoint

If the integration of Talkspace drives long‑term growth, the short‑term miss could be a buying opportunity.

Key entities

  • Universal Health Services

    U.S. hospital operator reporting Q3 2026 results.

  • Talkspace

    Behavioral health platform acquired by UHS.

Related articles

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

$CNCMed

Health insurers, hospitals rally after sweeping midterm win for Democrats

Shares of Medicaid-focused health insurers (Centene, Elevance, Molina) and hospital operators (HCA, Tenet, Universal) rose after Democrats won the midterms, raising hopes for sector-friendly policies. Analysts expect delays in Trump's OBBBA, easing pressure on Medicaid and ACA insurers, and potential extensions of enhanced subsidies. Year-to-date gains vary among companies.

$UHSHighAI 8/10

Softer surgery volumes, hospital woes dampened UHS’ Q3 earnings

Universal Health Services (UHS) lowered its 2026 earnings expectations due to declining surgeries and struggles at some hospitals. Q3 net income fell 17% to $308M, while revenues rose 5% to $4.7B. Challenges include lower surgery volumes, delays in new hospital profitability, and rising uninsured patients. UHS expects to be at the lower end of its guidance range for 2024.

$UHSMed

Guggenheim cuts Universal Health Services stock price target to $201 on weak Q3

Guggenheim reduced its price target for Universal Health Services (UHS) to $201 from $209, citing weak Q3 2026 EBITDA and macro pressures. UHS stock is down 8.5% in a week. The company lowered its 2026 EBITDA guidance but sees potential upside from expansions. UHS reported Q3 EPS of $5.22 and revenue of $4.73B, slightly beating estimates. Raymond James kept a Market Perform rating, noting softer profit trends and a cautious 2027 outlook.